Prognostic impact of preoperative immunonutritional status in rectal mucinous adenocarcinoma

References

• Hyngstrom JR , HuCY, XingYet al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann. Surg. Oncol.19(9), 2814–2821 (2012).
   PubMed Web of Science ®Google Scholar
• Hugen N , BrownG, Glynne-JonesR, de WiltJH, NagtegaalID. Advances in the care of patients with mucinous colorectal cancer. Nat. Rev. Clin. Oncol.13(6), 361–369 (2016).
   PubMed Web of Science ®Google Scholar
• Hugen N , vande Velde CJ, BoschSLet al. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma. Ann. Surg. Oncol.22(8), 2669–2676 (2015).
   PubMed Web of Science ®Google Scholar
• McCawley N , ClancyC, O’NeillBD, DeasyJ, McNamaraDA, BurkeJP. Mucinous rectal adenocarcinoma is associated with a poor response to neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Dis. Colon Rectum59(12), 1200–1208 (2016).
   PubMed Web of Science ®Google Scholar
• Read JA , ChoyST, BealePJ, ClarkeSJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr. Cancer55(1), 78–85 (2006).
   PubMed Web of Science ®Google Scholar
• Iseki Y , ShibutaniM, MaedaKet al. The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer. Surg. Today47(6), 743–754 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhuJY, ZhouLN, TangM, ChenMB, TaoM. Predicting the prognosis of gastric cancer by albumin/globulin ratio and the prognostic nutritional index. Nutr. Cancer1–10 (2019).
   Web of Science ®Google Scholar
• Toiyama Y , OkiS, OkugawaYet al. Clinical impact of preoperative albumin-globulin ratio in patients with rectal cancer treated with preoperative chemoradiotherapy. Oncology95(5), 270–280 (2018).
   PubMed Web of Science ®Google Scholar
• Xuan Q , YangY, JiHet al. Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer. Cancer Manag. Res.11, 5125–5131 (2019).
   PubMed Web of Science ®Google Scholar
• Yoshino Y , TaguchiA, ShimizuguchiTet al. A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy. Int. J. Gynecol. Cancer29(1), 17–22 (2019).
   PubMed Web of Science ®Google Scholar
• Mohri T , MohriY, ShigemoriT, TakeuchiK, ItohY, KatoT. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J. Surg. Oncol.14(1), 170 (2016).
   PubMed Web of Science ®Google Scholar
• Bozkaya Y , KostekO, SakinA, OzyukselerDT, SakalarT, CilI. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?Support. Care Cancer (doi: 10.1007/s00520-019-05055-x) (2019) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Camp RL , Dolled-FilhartM, RimmDL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res.10(21), 7252–7259 (2004).
   PubMed Web of Science ®Google Scholar
• Pande R , SungaA, LeveaCet al. Significance of signet-ring cells in patients with colorectal cancer. Dis. Colon Rectum51(5), 50–55 (2008).
   PubMed Web of Science ®Google Scholar
• Mekenkamp LJ , HeesterbeekKJ, KoopmanMet al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur. J. Cancer48(4), 501–509 (2012).
   PubMed Web of Science ®Google Scholar
• Kang H , O’ConnellJB, MaggardMA, SackJ, KoCY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis. Colon Rectum48(6), 1161–1168 (2005).
   PubMed Web of Science ®Google Scholar
• Schwegler I , von HolzenA, GutzwillerJP, SchlumpfR, MuhlebachS, StangaZ. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br. J. Surg.97(1), 92–97 (2010).
   PubMed Web of Science ®Google Scholar
• De Felice F , MusioD, MagnanteAL, BulzonettiN, TomboliniV. Excess of weight: is it a modifiable predictive and prognostic factor in locally advanced rectal cancer?Eur. Rev. Med. Pharmacol. Sci.21(20), 4606–4612 (2017).
   PubMed Web of Science ®Google Scholar
• De Felice F , IzzoL, MusioDet al. Clinical predictive factors of pathologic complete response in locally advanced rectal cancer. Oncotarget7(22), 33374–33380 (2016).
   PubMedGoogle Scholar
• Jung SW , ParkIJ, OhSHet al. Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer. Oncotarget8(35), 59757–59765 (2017).
   PubMedGoogle Scholar
• Gupta D , LisCG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr. J.9, 69 (2010).
   PubMed Web of Science ®Google Scholar
• Meyer EJ , NenkeMA, RankinW, LewisJG, TorpyDJ. Corticosteroid-binding globulin: a review of basic and clinical advances. Horm. Metab. Res.48(6), 359–371 (2016).
   PubMed Web of Science ®Google Scholar
• Hill LA , BodnarTS, WeinbergJ, HammondGL. Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats. J. Endocrinol.230(2), 215–225 (2016).
   PubMed Web of Science ®Google Scholar
• Chi J , XieQ, JiaJet al. Prognostic value of albumin/globulin ratio in survival and lymph node metastasis in patients with cancer: a systematic review and meta-analysis. J. Cancer9(13), 2341–2348 (2018).
   PubMed Web of Science ®Google Scholar
• Azab B , KediaS, ShahNet al. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int. J. Colorectal Dis.28(12), 1629–1636 (2013).
   PubMed Web of Science ®Google Scholar
• Shibutani M , MaedaK, NagaharaHet al. The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer. BMC Cancer15, 347 (2015).
   PubMed Web of Science ®Google Scholar
• Luo Z , ZhouL, BaldeAIet al. Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: a multicenter propensity score analysis. Eur. J. Surg. Oncol.45(3), 425–431 (2019).
   PubMed Web of Science ®Google Scholar
• Hu Y , ShenJ, LiuRet al. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis. Int. J. Biol. Markers33(4), 372–378 (2018).
   PubMed Web of Science ®Google Scholar
• Feng Z , WenH, JuXet al. The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer. BMC Cancer18(1), 883 (2018).
   PubMedGoogle Scholar
• Okugawa Y , ToiyamaY, OkiSet al. Feasibility of assessing prognostic nutrition index in patients with rectal cancer who receive preoperative chemoradiotherapy. J. Parenter. Enteral. Nutr.42(6), 998–1007 (2018).
   PubMed Web of Science ®Google Scholar
• Lee YJ , KimWR, HanJet al. Prognostic impact of immunonutritional status changes during preoperative chemoradiation in patients with rectal cancer. Ann. Coloproctol.32(6), 208–214 (2016).
   PubMedGoogle Scholar
• Kanda M , MizunoA, TanakaCet al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore)95(24), e3781 (2016).
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I , CropetC, Van GlabbekeMet al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res.69(13), 5383–5391 (2009).
   PubMed Web of Science ®Google Scholar
• Li Q , MengX, LiangL, XuY, CaiG, CaiS. High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome. Am. J. Cancer Res.5(9), 2856–2864 (2015).
   PubMed Web of Science ®Google Scholar
• Colotta F , AllavenaP, SicaA, GarlandaC, MantovaniA. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis30(7), 1073–1081 (2009).
   PubMed Web of Science ®Google Scholar
• Cai B , ChenH, SunH, WanP, SunH, PanJ. Production of immunoregulatory polysaccharides from Crassostrea hongkongensis and their positive effects as a nutrition factor in modulating the effectiveness and toxicity of 5-FU chemotherapy in mice. Food Funct.7(1), 390–397 (2016).
   PubMed Web of Science ®Google Scholar
• Mahar AL , ComptonC, HalabiS, HessKR, WeiserMR, GroomePA. Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J. Surg. Oncol.116(8), 969–982 (2017).
   PubMed Web of Science ®Google Scholar
• Yu SK , ChandM, TaitDM, BrownG. Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur. J. Cancer50(5), 920–927 (2014).
   PubMed Web of Science ®Google Scholar
• Prieto I , MontemuinoS, LunaJ, de TorresMV, AmayaE. The role of immunonutritional support in cancer treatment: current evidence. Clin. Nutr.36(6), 1457–1464 (2017).
   PubMed Web of Science ®Google Scholar
• Burden S , ToddC, HillJ, LalS. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst. Rev.11, D8879 (2012).
   Google Scholar
• Paccagnella A , MorassuttiI, RostiG. Nutritional intervention for improving treatment tolerance in cancer patients. Curr. Opin. Oncol.23(4), 322–330 (2011).
   PubMed Web of Science ®Google Scholar
• Ravasco P , Monteiro-GrilloI, CamiloM. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am. J. Clin. Nutr.96(6), 1346–1353 (2012).
   PubMed Web of Science ®Google Scholar